SMS PHARMACEUTICALS
|
The Current P/E Ratio of SMS PHARMACEUTICALS is 42.89.
Share Price | ₹208.7 | Apr 24,2024 |
Market Cap | ₹1,767.7 Cr | |
Earnings-TTM | ₹41.2 Cr | TTM-Consolidated Results |
Price/Earnings | 42.89x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SMS PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,767.7 Cr] as on Apr 24,2024
(/) Earnings [ ₹41.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 42.89x ]
Thus, for SMS PHARMACEUTICALS , the investors are currently willing to pay 42.89 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SMS PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SMS PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SMS PHARMACEUTICALS
PE Ratio Performance Analysis for SMS PHARMACEUTICALS
- SMS PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 9.98x.
- SMS PHARMACEUTICALS 's operated at median p/e ratio of 12.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SMS PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 16.84x.
- SMS PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SMS PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SMS PHARMACEUTICALS | 41.21 | 42.89 | 1,767.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 39.63 | 356,625.0 |
CIPLA LTD | 3,744.03 | 30.16 | 112,938.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.06 | 99,276.9 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 31.79 | 93,921.9 |
DIVIS LABORATORIES LTD | 1,382.97 | 73.26 | 101,315.0 |
MANKIND PHARMA LTD | 1,743.30 | 55.15 | 96,143.2 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 60.83 | 90,872.6 |
LUPIN LTD | 1,809.74 | 39.79 | 72,010.8 |
AUROBINDO PHARMA LTD | 2,777.89 | 22.86 | 63,492.3 |
ABBOTT INDIA LTD | 1,145.58 | 47.23 | 54,105.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SMS PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.06x |
Max industry PE | 73.26x |
Median industry PE | 39.79x |
Average industry PE | 42.06x |
You may also like the below Video Courses